XML 56 R43.htm IDEA: XBRL DOCUMENT v3.24.0.1
Segment and Geographic Reporting (Tables)
12 Months Ended
Dec. 31, 2023
Disaggregation of Revenue [Line Items]  
Schedule of Condensed Income Statement by Segment

Year Ended December 31, 2023

    

Investment

    

Energy

    

Automotive

    

Food Packaging

    

Real Estate

    

Home Fashion

    

Pharma

    

Holding Company

    

Consolidated

(in millions)

Revenues:

Net sales

$

$

9,247

$

1,047

$

446

$

69

$

175

$

93

$

$

11,077

Other revenues from operations

 

 

 

694

 

 

73

 

 

3

 

 

770

Net loss from investment activities

 

(1,575)

 

 

 

 

 

 

 

 

(1,575)

Interest and dividend income

 

497

 

38

 

3

 

 

 

 

1

 

97

 

636

(Loss) gain on disposition of assets, net

 

 

(2)

 

10

 

 

 

 

 

 

8

Other (loss) gain, net

 

(87)

 

14

 

 

(11)

 

1

 

 

1

 

13

 

(69)

 

(1,165)

 

9,297

 

1,754

 

435

 

143

 

175

 

98

 

110

 

10,847

Expenses:

Cost of goods sold

 

 

8,019

 

714

 

352

 

48

 

138

 

56

 

 

9,327

Other expenses from operations

 

 

 

581

 

 

62

 

 

 

 

643

Selling, general and administrative

 

26

 

168

 

465

 

54

 

17

 

41

 

45

 

36

 

852

Restructuring, net

 

 

 

 

 

 

1

 

 

 

1

Impairment

7

7

Credit loss on notes receivable

139

139

Loss on deconsolidation

246

246

Interest expense

 

162

 

90

 

3

 

12

 

 

1

 

 

286

 

554

 

188

 

8,277

 

1,770

 

418

 

127

 

181

 

101

 

707

 

11,769

(Loss) income from continuing operations before income tax (expense) benefit

 

(1,353)

 

1,020

 

(16)

 

17

 

16

 

(6)

 

(3)

 

(597)

 

(922)

Income tax (expense) benefit

 

 

(189)

 

10

 

(4)

 

 

 

 

93

 

(90)

Net (loss) income

 

(1,353)

 

831

 

(6)

 

13

 

16

 

(6)

 

(3)

 

(504)

 

(1,012)

Less: net (loss) income from continuing operations attributable to non-controlling interests

 

(652)

 

323

 

 

1

 

 

 

 

 

(328)

Net (loss) income from continuing operations attributable to Icahn Enterprises

$

(701)

$

508

$

(6)

$

12

$

16

$

(6)

$

(3)

$

(504)

$

(684)

Supplemental information:

Capital expenditures

$

$

205

$

79

$

14

$

3

$

2

$

$

$

303

Depreciation and amortization

$

$

363

$

81

$

25

$

13

$

7

$

28

$

1

$

518

Year Ended December 31, 2022

    

Investment

    

Energy

    

Automotive

    

Food Packaging

    

Real Estate

    

Home Fashion

    

Pharma

    

Holding Company

 

Consolidated

(in millions)

Revenues:

Net sales

$

$

10,896

$

1,707

$

431

$

61

$

217

$

66

$

$

13,378

Other revenues from operations

 

 

 

687

 

 

57

 

 

4

 

 

748

Net (loss) gain from investment activities

 

(216)

 

 

 

 

 

 

 

48

 

(168)

Interest and dividend income

 

288

 

8

 

 

 

 

 

1

 

31

 

328

(Loss) gain on disposition of assets, net

 

 

(11)

 

3

 

 

 

 

 

 

(8)

Other (loss) gain, net

 

(95)

 

(78)

 

1

 

(5)

 

 

 

1

 

(1)

 

(177)

 

(23)

 

10,815

 

2,398

 

426

 

118

 

217

 

72

 

78

 

14,101

Expenses:

Cost of goods sold

 

 

9,811

 

1,247

 

357

 

40

 

186

 

48

 

 

11,689

Other expenses from operations

 

 

 

528

 

 

55

 

 

 

 

583

Selling, general and administrative

 

27

 

176

 

867

 

52

 

16

 

48

 

42

 

22

 

1,250

Restructuring, net

 

 

 

 

 

 

2

 

 

 

2

Impairment

Interest expense

 

173

 

92

 

2

 

8

 

 

3

 

 

290

 

568

 

200

 

10,079

 

2,644

 

417

 

111

 

239

 

90

 

312

 

14,092

(Loss) income from continuing operations before income tax (expense) benefit

 

(223)

 

736

 

(246)

 

9

 

7

 

(22)

 

(18)

 

(234)

 

9

Income tax (expense) benefit

 

 

(140)

 

54

 

(7)

 

 

 

 

59

 

(34)

Net (loss) income

 

(223)

 

596

 

(192)

 

2

 

7

 

(22)

 

(18)

 

(175)

 

(25)

Less: net (loss) income from continuing operations attributable to non-controlling interests

 

(134)

 

292

 

 

 

 

 

 

 

158

Net (loss) income from continuing operations attributable to Icahn Enterprises

$

(89)

$

304

$

(192)

$

2

$

7

$

(22)

$

(18)

$

(175)

$

(183)

Supplemental information:

Capital expenditures

$

$

191

$

114

$

22

$

9

$

2

$

$

$

338

Depreciation and amortization

$

$

353

$

80

$

27

$

13

$

7

$

28

$

1

$

509

Year Ended December 31, 2021

    

Investment

    

Energy

    

Automotive

    

Food Packaging

    

Real Estate

    

Home Fashion

    

Pharma

    

Metals

    

Holding Company

    

Consolidated

(in millions)

Revenues:

    

  

  

  

  

  

  

  

  

  

 

  

Net sales

$

$

7,242

$

1,789

$

416

$

55

$

197

$

81

$

524

$

$

10,304

Other revenues from operations

 

 

 

605

 

 

38

 

 

4

 

 

 

647

Net gain (loss) from investment activities

 

145

 

81

 

 

 

 

 

 

 

(33)

 

193

Interest and dividend income

 

132

 

 

 

 

 

 

 

 

5

 

137

(Loss) gain on disposition of assets, net

 

 

(3)

 

(22)

 

 

3

 

 

 

163

 

 

141

Other (loss) income, net

 

(75)

 

7

 

(2)

 

(14)

 

 

 

 

(3)

 

3

 

(84)

 

202

 

7,327

 

2,370

 

402

 

96

 

197

 

85

 

684

 

(25)

 

11,338

Expenses:

 

Cost of goods sold

 

 

7,069

 

1,339

 

343

 

44

 

159

 

50

 

481

 

 

9,485

Other expenses from operations

 

 

 

475

 

 

47

 

 

 

 

 

522

Selling, general and administrative

 

16

 

147

 

877

 

50

 

13

 

46

 

38

 

16

 

35

 

1,238

Restructuring, net

 

 

 

4

 

1

 

 

 

 

 

 

5

Impairment

 

Interest expense

 

218

 

109

 

7

 

6

 

 

2

 

 

1

 

323

 

666

 

234

 

7,325

 

2,702

 

400

 

104

 

207

 

88

 

498

 

358

 

11,916

(Loss) income from continuing operations before income tax benefit (expense)

 

(32)

 

2

 

(332)

 

2

 

(8)

 

(10)

 

(3)

 

186

 

(383)

 

(578)

Income tax benefit (expense)

 

 

27

 

72

 

(4)

 

 

2

 

 

 

(19)

 

78

Net (loss) income from continuing operations

 

(32)

 

29

 

(260)

 

(2)

 

(8)

 

(8)

 

(3)

 

186

 

(402)

 

(500)

Less: net (loss) income from continuing operations attributable to non-controlling interests

 

(16)

 

34

 

 

 

 

 

 

 

 

18

Net (loss) income from continuing operations attributable to Icahn Enterprises

$

(16)

$

(5)

$

(260)

$

(2)

$

(8)

$

(8)

$

(3)

$

186

$

(402)

$

(518)

Supplemental information:

 

Capital expenditures

$

$

224

$

48

$

17

$

10

$

3

$

$

3

$

$

305

Depreciation and amortization

$

$

343

$

87

$

28

$

9

$

7

$

28

$

14

$

1

$

517

Schedule of Condensed Financial Statements by Segment

December 31, 2023

Investment

Energy

Automotive

Food
Packaging

Real
Estate

Home
Fashion

    

Pharma

Holding
Company

Consolidated

(in millions)

ASSETS

Cash and cash equivalents

$

23

$

1,179

$

104

$

8

$

22

$

5

$

26

$

1,584

$

2,951

Cash held at consolidated affiliated partnerships and restricted cash

 

2,799

 

7

 

9

 

 

4

 

3

 

 

173

 

2,995

Investments

 

2,898

 

100

 

 

 

14

 

 

 

 

3,012

Accounts receivable, net

 

 

286

 

41

 

89

 

16

 

26

 

27

 

 

485

Related party note receivable

11

11

Inventories

 

 

604

 

228

 

111

 

 

81

 

23

 

 

1,047

Property, plant and equipment, net

 

 

2,594

 

822

 

134

 

363

 

52

 

 

4

 

3,969

Goodwill and intangible assets, net

 

 

179

 

335

 

23

 

 

19

 

198

 

 

754

Other assets

 

4,425

 

310

 

480

 

101

 

69

 

17

 

8

 

224

 

5,634

Total assets

$

10,145

$

5,259

$

2,019

$

466

$

488

$

203

$

282

$

1,996

$

20,858

LIABILITIES AND EQUITY

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

Accounts payable, accrued expenses and other liabilities

$

1,312

$

1,553

$

890

$

148

$

43

$

42

$

55

$

62

$

4,105

Securities sold, not yet purchased, at fair value

 

3,473

 

 

 

 

 

 

 

 

3,473

Debt

 

 

2,185

 

33

 

133

 

1

 

8

 

 

4,847

 

7,207

Total liabilities

 

4,785

 

3,738

 

923

 

281

 

44

 

50

 

55

 

4,909

 

14,785

Equity attributable to Icahn Enterprises

 

3,243

 

795

 

1,096

 

168

 

439

 

153

 

227

 

(2,913)

 

3,208

Equity attributable to non-controlling interests

 

2,117

 

726

 

 

17

 

5

 

 

 

 

2,865

Total equity

 

5,360

 

1,521

 

1,096

 

185

 

444

 

153

 

227

 

(2,913)

 

6,073

Total liabilities and equity

$

10,145

$

5,259

$

2,019

$

466

$

488

$

203

$

282

$

1,996

$

20,858

December 31, 2022

Investment

Energy

Automotive

Food
Packaging

Real
Estate

Home
Fashion

    

Pharma

Holding
Company

Consolidated

(in millions)

ASSETS

Cash and cash equivalents

$

19

$

510

$

32

$

9

$

26

$

5

$

16

$

1,720

$

2,337

Cash held at consolidated affiliated partnerships and restricted cash

 

2,455

 

7

 

10

 

 

8

 

3

 

 

66

 

2,549

Investments

 

6,719

 

76

 

 

 

14

 

 

 

 

6,809

Accounts receivable, net

 

 

358

 

99

 

87

 

12

 

24

 

26

 

 

606

Inventories

 

 

624

 

686

 

103

 

 

90

 

28

 

 

1,531

Property, plant and equipment, net

 

 

2,664

 

826

 

142

 

345

 

56

 

 

5

 

4,038

Goodwill and intangible assets, net

 

 

200

 

352

 

24

 

 

19

 

226

 

 

821

Other assets

 

8,041

 

296

 

527

 

110

 

102

 

16

 

6

 

125

 

9,223

Total assets

$

17,234

$

4,735

$

2,532

$

475

$

507

$

213

$

302

$

1,916

$

27,914

LIABILITIES AND EQUITY

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

Accounts payable, accrued expenses and other liabilities

$

1,589

$

1,823

$

981

$

149

$

47

$

45

$

61

$

70

$

4,765

Securities sold, not yet purchased, at fair value

 

6,495

 

 

 

 

 

 

 

 

6,495

Debt

 

 

1,591

 

21

 

162

 

1

 

12

 

 

5,309

 

7,096

Total liabilities

 

8,084

 

3,414

 

1,002

 

311

 

48

 

57

 

61

 

5,379

 

18,356

Equity attributable to Icahn Enterprises

 

4,184

 

648

 

1,530

 

149

 

455

 

156

 

241

 

(3,463)

 

3,900

Equity attributable to non-controlling interests

 

4,966

 

673

 

 

15

 

4

 

 

 

 

5,658

Total equity

 

9,150

 

1,321

 

1,530

 

164

 

459

 

156

 

241

 

(3,463)

 

9,558

Total liabilities and equity

$

17,234

$

4,735

$

2,532

$

475

$

507

$

213

$

302

$

1,916

$

27,914

Geographic Information

Property, Plant and

Net Sales

Other Revenues From Operations

Equipment, Net

Year Ended December 31, 

Year Ended December 31, 

December 31, 

    

2023

    

2022

    

2021

    

2023

    

2022

    

2021

    

2023

    

2022

(in millions)

United States

$

10,687

$

12,988

$

9,924

$

742

$

722

$

636

$

3,844

$

3,921

International

 

390

 

390

 

380

 

28

 

26

 

11

 

125

 

117

$

11,077

$

13,378

$

10,304

$

770

$

748

$

647

$

3,969

$

4,038

Energy  
Disaggregation of Revenue [Line Items]  
Disaggregation of Revenue

Year Ended December 31, 

    

2023

    

2022

    

2021

(in millions)

Petroleum products

$

8,566

$

10,060

$

6,709

Nitrogen fertilizer products

 

681

 

836

 

533

$

9,247

$

10,896

$

7,242

Automotive Segment  
Disaggregation of Revenue [Line Items]  
Disaggregation of Revenue

Year Ended December 31, 

    

2023

    

2022

    

2021

(in millions)

Automotive Services

$

1,548

$

1,552

$

1,377

Aftermarket Parts sales

 

137

 

797

 

1,007

Total revenue from customers

1,685

2,349

2,384

Lease revenue outside scope ASC 606

56

45

10

Total Automotive net sales and other revenues from operations

$

1,741

$

2,394

$

2,394